{"disease":{"id":"variant-angina","name":"variant angina"},"drugs":{"marketed":[{"drug_id":"caduet","indication_name":"Vasospastic Angina (Prinzmetal’s or Variant Angina)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Caduet","generic_name":"Amlodipine Besylate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"L-type calcium channel","drug_class":"Dihydropyridine calcium channel blocker","quality_score":76,"revenue":null,"mechanism":"Calcium channel antagonist inhibiting transmembrane calcium influx into vascular and cardiac muscle."},{"drug_id":"verapamil-hydrochloride","indication_name":"Vasospastic (Prinzmetal's variant) angina","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Verapamil Hydrochloride","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"L-type calcium channels (slow channels)","drug_class":"Calcium channel blocker","quality_score":56,"revenue":null,"mechanism":"Calcium ion influx inhibitor that modulates ionic calcium across cell membranes of arterial smooth muscle and myocardial cells."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03228238","title":"ANti-Oxidant in Variant Angina (ANOVA) Trial","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03477890","title":"Coronary Microvascular Function and CT Coronary Angiography (CorCTCA)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":250,"lead_sponsor_name":"NHS National Waiting Times Centre Board","has_results":false},{"nct_id":"NCT01674686","title":"The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT05618132","title":"ReACHallenge Trial: Acetylcholine Rechallenge After Pretreatment With Vasoactive Drugs","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"University Hospital, Antwerp","has_results":false},{"nct_id":"NCT06992830","title":"Cardioneuroablation for Variant Angina","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":16,"lead_sponsor_name":"Zhibing Lu","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}